---
title: "Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression | ANRO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283495877.md"
description: "Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression | ANRO Stock News"
datetime: "2026-04-21T04:05:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283495877.md)
  - [en](https://longbridge.com/en/news/283495877.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283495877.md)
---

# Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression | ANRO Stock News

Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression | ANRO Stock News

### Related Stocks

- [ANRO.US](https://longbridge.com/en/quote/ANRO.US.md)
- [XPH.US](https://longbridge.com/en/quote/XPH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PSIL.US](https://longbridge.com/en/quote/PSIL.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBRN.US](https://longbridge.com/en/quote/IBRN.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PILL.US](https://longbridge.com/en/quote/PILL.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)

## Related News & Research

- [Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights | ANRO Stock News](https://longbridge.com/en/news/286247939.md)
- [BioMarin's drug shows significant growth gains in children in late-stage trial](https://longbridge.com/en/news/287121584.md)
- [09:24 ETTigerlily Foundation Collaborates with Bristol Myers Squibb to Advance Clinical Trial Access and Equity](https://longbridge.com/en/news/286573689.md)
- [Capricor publishes investor presentation on deramiocel Duchenne muscular dystrophy program](https://longbridge.com/en/news/287222906.md)
- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)